Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

Related Articles by Review for PubMed (Select 18727667)

1.

Hydroxychloroquine-induced hyperpigmentation: the staining pattern.

Puri PK, Lountzis NI, Tyler W, Ferringer T.

J Cutan Pathol. 2008 Dec;35(12):1134-7. doi: 10.1111/j.1600-0560.2008.01004.x. Epub 2008 Aug 23.

PMID:
18727667
2.

Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.

Nord JE, Shah PK, Rinaldi RZ, Weisman MH.

Semin Arthritis Rheum. 2004 Apr;33(5):336-51. Review.

PMID:
15079764
3.

Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.

Aylward JM.

J Am Optom Assoc. 1993 Nov;64(11):787-97. Review.

PMID:
8120333
4.

Imipramine-induced hyperpigmentation: a case report and review of the literature.

D'Agostino ML, Risser J, Robinson-Bostom L.

J Cutan Pathol. 2009 Jul;36(7):799-803. doi: 10.1111/j.1600-0560.2008.01121.x. Review.

PMID:
19519613
5.

Systemic lupus erythematosus: safe and effective management in primary care.

Michalski JP, Kodner C.

Prim Care. 2010 Dec;37(4):767-78, vii. doi: 10.1016/j.pop.2010.07.006. Review.

PMID:
21050957
6.

Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature.

Paradisi A, Bugatti L, Sisto T, Filosa G, Amerio PL, Capizzi R.

Clin Ther. 2008 May;30(5):930-40. doi: 10.1016/j.clinthera.2008.05.014. Review.

PMID:
18555940
7.

Hydroxychloroquine neuromyotoxicity.

Stein M, Bell MJ, Ang LC.

J Rheumatol. 2000 Dec;27(12):2927-31. Review.

PMID:
11128688
8.

Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.

Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY.

Can J Cardiol. 2014 Dec;30(12):1706-15. doi: 10.1016/j.cjca.2014.08.016. Epub 2014 Aug 23. Review.

PMID:
25475472
9.

Imipramine-induced hyperpigmentation: four cases and a review of the literature.

Ming ME, Bhawan J, Stefanato CM, McCalmont TH, Cohen LM.

J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):159-66. Review.

PMID:
10025739
10.
11.
12.

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.

Costedoat-Chalumeau N, Amoura Z, Huong DL, Lechat P, Piette JC.

Autoimmun Rev. 2005 Feb;4(2):111-5. Epub 2004 Dec 14. Review.

PMID:
15722258
13.

A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.

Houpt JB.

J Rheumatol. 1999 Sep;26(9):1864-6. Review. No abstract available.

PMID:
10493661
14.

Insights into atherosclerosis therapy in antiphospholipid syndrome.

Belizna CC, Richard V, Thuillez C, Lévesque H, Shoenfeld Y.

Autoimmun Rev. 2007 Nov;7(1):46-51. Epub 2007 Jul 18. Review.

PMID:
17967725
15.

[Drug agents for the treatment of systemic connective tissue diseases].

Shishmanov D.

Vutr Boles. 1988;27(5):61-5. Review. Bulgarian.

PMID:
3062901
16.

[Retinal pigment epithelium--the point about safety of antimalarial agents].

Vanheesbeke A.

Bull Soc Belge Ophtalmol. 2007;(304):47-58. Review. French.

PMID:
17718227
17.

Canadian Consensus Conference on hydroxychloroquine.

Canadian rheumatology association.

J Rheumatol. 2000 Dec;27(12):2919-21. Review. No abstract available.

PMID:
11128686
18.

[Ocular toxicity induced by medication].

Garralda Luquin A.

An Sist Sanit Navar. 2008;31 Suppl 3:147-53. Review. Spanish.

19.

Drug-induced lupus erythematosus.

Vedove CD, Del Giglio M, Schena D, Girolomoni G.

Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Review.

PMID:
18797892
20.

Cardiac damage from chronic use of chloroquine: a case report and review of the literature.

Teixeira RA, Martinelli Filho M, Benvenuti LA, Costa R, Pedrosa AA, Nishióka SA.

Arq Bras Cardiol. 2002 Jul;79(1):85-8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk